Compare, Analyse GRANULES INDIA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GRANULES INDIA   TEVA PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
TEVA PHARMA
Dec-13
GRANULES INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4383,135-   
Low Rs1382,723-   
Sales per share (Unadj.) Rs130.71,799.3-  
Earnings per share (Unadj.) Rs22.2112.4-  
Cash flow per share (Unadj.) Rs28.3257.8-  
Dividends per share (Unadj.) Rs1.5098.39-  
Avg Dividend yield %0.53.4 15.5%  
Book value per share (Unadj.) Rs86.81,998.7-  
Shares outstanding (eoy) m247.67848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.21.6 135.3%   
Avg P/E ratio x13.026.1 49.8%  
P/CF ratio (eoy) x10.211.4 89.6%  
Price / Book Value ratio x3.31.5 226.3%  
Dividend payout %6.887.5 7.7%   
Avg Mkt Cap Rs m71,3372,484,038 2.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3,2430-   
Avg. sales/employee Rs ThNM33,947.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,120.7-  
INCOME DATA
Net Sales Rs m32,3751,525,785 2.1%  
Other income Rs m2690-   
Total revenues Rs m32,6441,525,785 2.1%   
Gross profit Rs m8,552417,837 2.0%  
Depreciation Rs m1,515123,331 1.2%   
Interest Rs m26329,969 0.9%   
Profit before tax Rs m7,044264,537 2.7%   
Minority Interest Rs m01,202 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,654 0.0%   
Tax Rs m1,549-3,230 -48.0%   
Profit after tax Rs m5,49595,315 5.8%  
Gross profit margin %26.427.4 96.5%  
Effective tax rate %22.0-1.2 -1,801.3%   
Net profit margin %17.06.2 271.7%  
BALANCE SHEET DATA
Current assets Rs m19,9701,030,509 1.9%   
Current liabilities Rs m11,731898,691 1.3%   
Net working cap to sales %25.48.6 294.6%  
Current ratio x1.71.1 148.5%  
Inventory Days Days1691 18.0%  
Debtors Days Days86396 899.7%  
Net fixed assets Rs m17,157498,355 3.4%   
Share capital Rs m2483,756 6.6%   
"Free" reserves Rs m21,2620-   
Net worth Rs m21,5101,694,857 1.3%   
Long term debt Rs m3,411780,168 0.4%   
Total assets Rs m37,1273,486,907 1.1%  
Interest coverage x27.89.8 282.9%   
Debt to equity ratio x0.20.5 34.5%  
Sales to assets ratio x0.90.4 199.3%   
Return on assets %15.53.6 431.6%  
Return on equity %25.55.6 454.2%  
Return on capital %29.34.9 594.5%  
Exports to sales %81.90-   
Imports to sales %26.80-   
Net fx Rs m17,8370-   
CASH FLOW
From Operations Rs m4,325243,131 1.8%  
From Investments Rs m-2,771-86,151 3.2%  
From Financial Activity Rs m-2,993-291,652 1.0%  
Net Cashflow Rs m-1,441-134,672 1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.11 Rs / USD

Compare GRANULES INDIA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare GRANULES INDIA With: INDOCO REMEDIES  COLINZ LABOR  ALKEM LABORATORIES  EVEREST ORGANICS  LASA SUPERGENERICS  



Today's Market

Sensex Recoups Early Losses as Energy, Metal Stocks Rally; Reliance & Tata Steel Top Gainers(10:30 am)

Asian share markets are trading lower today as the spread of the Omicron variant in developed nations threatened to derail economic recoveries and the tightening plans of some central banks.

Related Views On News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GRANULES INDIA SHARE PRICE


Nov 29, 2021 11:49 AM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 8-QTR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS